Cryo-Cell International Management
Management criteria checks 2/4
Cryo-Cell International's CEO is David Portnoy, appointed in Aug 2011, has a tenure of 13.33 years. total yearly compensation is $1.87M, comprised of 37.4% salary and 62.6% bonuses, including company stock and options. directly owns 16.91% of the company’s shares, worth $10.56M. The average tenure of the management team and the board of directors is 13.3 years and 8.3 years respectively.
Key information
David Portnoy
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 37.4% |
| CEO tenure | 13.3yrs |
| CEO ownership | 16.9% |
| Management average tenure | 13.3yrs |
| Board average tenure | 8.3yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Aug 31 2024 | n/a | n/a | -US$9m |
| May 31 2024 | n/a | n/a | -US$9m |
| Feb 29 2024 | n/a | n/a | -US$10m |
| Nov 30 2023 | US$2m | US$700k | -US$10m |
| Aug 31 2023 | n/a | n/a | US$3m |
| May 31 2023 | n/a | n/a | US$2m |
| Feb 28 2023 | n/a | n/a | US$3m |
| Nov 30 2022 | US$1m | US$620k | US$3m |
| Aug 31 2022 | n/a | n/a | US$1m |
| May 31 2022 | n/a | n/a | US$2m |
| Feb 28 2022 | n/a | n/a | US$2m |
| Nov 30 2021 | US$1m | US$620k | US$2m |
| Aug 31 2021 | n/a | n/a | US$4m |
| May 31 2021 | n/a | n/a | US$4m |
| Feb 28 2021 | n/a | n/a | US$4m |
| Nov 30 2020 | US$754k | US$602k | US$4m |
| Aug 31 2020 | n/a | n/a | US$3m |
| May 31 2020 | n/a | n/a | US$4m |
| Feb 29 2020 | n/a | n/a | US$3m |
| Nov 30 2019 | US$687k | US$602k | US$2m |
| Aug 31 2019 | n/a | n/a | US$2m |
| May 31 2019 | n/a | n/a | US$1m |
| Feb 28 2019 | n/a | n/a | US$2m |
| Nov 30 2018 | US$982k | US$547k | -US$855k |
Compensation vs Market: David's total compensation ($USD1.87M) is above average for companies of similar size in the US market ($USD650.00K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Portnoy (61 yo)
13.3yrs
Tenure
US$1,869,397
Compensation
Mr. David I. Portnoy has been Co-Chief Executive Officer of Cryo-Cell International, Inc. since August 31, 2011. Mr. Portnoy serves as the President of Focus Financial Corp., a private investment banking a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Co-CEO | 13.3yrs | US$1.87m | 16.91% $ 10.6m | |
| Co-CEO & Director | 13.3yrs | US$1.19m | 11.61% $ 7.3m | |
| CFO & VP of Finance | 26.6yrs | US$307.30k | 0.56% $ 351.8k | |
| Chief Information Officer | 12.8yrs | US$432.28k | 1.29% $ 808.7k | |
| Medical Director and Member of Medical & Scientific Advisory Board | 6.5yrs | no data | no data |
13.3yrs
Average Tenure
57yo
Average Age
Experienced Management: CCEL's management team is seasoned and experienced (13.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & Co-CEO | 13.3yrs | US$1.87m | 16.91% $ 10.6m | |
| Co-CEO & Director | 3.3yrs | US$1.19m | 11.61% $ 7.3m | |
| Medical Director and Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 13.3yrs | US$72.34k | 0.63% $ 390.6k | |
| Member of Medical & Scientific Advisory Board | no data | US$47.87k | no data | |
| Independent Director | 3.3yrs | US$72.34k | 0.38% $ 237.4k |
8.3yrs
Average Tenure
60yo
Average Age
Experienced Board: CCEL's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 11:44 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/08/31 |
| Annual Earnings | 2023/11/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cryo-Cell International, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Allen Klee | Maxim Group |